ImmuCell Corporation: cash_and_equivalents
| Value | {"amount": 6202663, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-06-30) |
| Status | current |
| Entity | ImmuCell Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:07:42.348763+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/09e463b1-670b-488e-8843-880e97461054
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-20-021605Retrieved: 2026-08-19T08:07:42.348763+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000811641/cash-and-equivalents/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/09e463b1-670b-488e-8843-880e97461054
History
- no predecessors — first report